MLMark Aaron Law

Mark Aaron Law

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark Aaron Law has a total of 216 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Timing and Mode of Death Following Treatment of Neonatal Symptomatic Tetralogy of Fallot

    by Sara M. Trucco, Yun Zhang, Andrew C. Glatz, Michael L. O’BYrne, Christopher J. Petit, Athar M. Qureshi, Jeffrey D. Zampi, Shabana Shahanavaz, George T. Nicholson, Allen Ligon, et al.

    Background: Neonates with tetralogy of Fallot and symptomatic cyanosis (sTOF) require early intervention, using a staged or primary repair strategy. Postprocedural mortality risk within this group is considerable. The mode of death and associated factors have been inadequately defined in early childhood mortality following treatment of sTOF. This study aims to describe the timing, cause, and associated risk factors of postprocedural death in infants with sTOF. Methods: Neonates with sTOF who had an initial intervention from 2005 to 2017 at 9 centers of the Congenital Cardiac Research Collaborative were reviewed. Among nonsurvivors, details regarding timing, cause of death, and last follow‐up were obtained. Patient characteristics between survivors and nonsurvivors were compared. Results: Of 572 patients with sTOF (230 primary repair, 342 staged repair), 52 (9%) died at a median age of 82 (25th–75th%ile: 28–246) days. Death was perioperative (≤30 days) in 52% of cases. Most deaths were cardiac (69%, n=36), with heart failure and sudden death being most common. Noncardiac causes included necrotizing enterocolitis (n=3), infectious (n=3), and intracranial hemorrhage (n=2). Risk factors for mortality included prematurity, low birth weight, genetic syndrome, race categorized as other, noncardiac anomaly, and ventilation before initial intervention ( P <0.05 for all). Among patients discharged after definitive repair, right ventricular dysfunction was more common in nonsurvivors. Sudden death is a prominent known cause of death in this subgroup. Conclusions: When death occurs after interventions for sTOF, it frequently occurs early and relates to traditional risk factors. Sudden death is a prominent cause of mortality following discharge from definitive repair.


  • Open Access

    Race and the Inaccuracy of Pulse Oximetry With Hypoxemia in a Pediatric Cardiac ICU

    by Matthew T. Coghill, Mark A. Law, Lece V. Webb, Ahmed Asfari, Santiago Borasino

    OBJECTIVES: To ascertain the potential effects of hypoxemia and race on pulse oximetry in a population of patients, including those for whom hypoxemia is a normal state secondary to intracardiac mixing in an ICU setting. DESIGN: Retrospective, observational, cohort study. SETTING: A single center’s pediatric cardiac ICU (CICU). PATIENTS: Eight hundred forty-one patients undergoing bypass operations during a 52-month period (June 2019–October 2023). Predominantly, patients with congenital heart disease. The median age was 7.1 months with 58% younger than 1 year old and 88% younger than 10 years old. INTERVENTIONS: Arterial blood saturations, as measured by a hemoximeter, were recorded for all patients after bypass operations. These were time-matched, with high-fidelity, to pulse oximeter values. MEASUREMENTS AND MAIN RESULTS: The mean oximetric difference, or “pulse oximetry overestimation,” was defined as arterial oxygen saturation minus that predicted by pulse oximetry, was greater for Black than for White patients (–3.18% vs. –2.19%, p = 0.006). Regression shows a significant effect of Sao 2 on oximetric difference (p < 0.001) and mildly significant trend for the categorical race (p = 0.03) as well as their composite interaction term (p = 0.047). Oximetric difference was exaggerated with increasing hypoxemia. At normal oxygen saturations, the oximetric difference was greater for Black when compared with White patients (p = 0.002 for patients with Sao 2 > 94%). This effect if race is not statistically significant at other Sao 2 ranges that are clinically important in patients with intracardiac mixing. CONCLUSIONS: This study redemonstrates effect of increasing hypoxemia on oximetric difference. Race may have an independent effect on oximetric difference. This adds to the body of literature that has previously suggested that pulse oximetry, relied upon as a vital sign, may introduce explicit race-related bias into the bedside interpretation of a patient’s clinical state.


  • Open Access

    Outcomes Following Balloon Pulmonary Valvuloplasty in Symptomatic Neonates With Tetralogy of Fallot—A CCRC Study

    by Shabana Shahanavaz, Athar M. Qureshi, Christopher J. Petit, Bryan H. Goldstein, Andrew C. Glatz, Holly Bauser-Heaton, Courtney E. McCracken, Michael S. Kelleman, George T. Nicholson, Jeffrey D. Zampi, et al.


  • Open Access

    D-15 | Radiation Exposure from Cardiac Catheterization in Neonates With Symptomatic Tetralogy of Fallot

    by Jeannette R. Wong-Siegel, Andrew C. Glatz, Courtney McCracken, Choonsik Lee, Lene Veiga, Cari M. Kitahara, Tacy Downing, Bryan H. Goldstein, Christopher J. Petit, Athar M. Qureshi, et al.

  • CUMULATIVE RADIATION EXPOSURE IN NEONATES WITH SYMPTOMATIC TETRALOGY OF FALLOT REQUIRING EARLY INTERVENTION

    by Jeannette Wong-Siegel, Andrew C. Glatz, Courtney McCracken, Tacy E. Downing, Bryan H. Goldstein, Christopher J. Petit, Athar M. Qureshi, George T. Nicholson, Mark Aaron Law, Jeffery Meadows, et al.

  • Association Between Venous Homografts and Allosensitization After Norwood Procedure

    by Christian H Tan, David C Cleveland, Robert J Dabal, Luz A Padilla, Kathryn S Maxwell, Mark A Law, Waldemar F Carlo, Santiago Borasino, Robert A Sorabella

    Background: Right ventricle (RV) to pulmonary artery (PA) shunts have become the shunt of choice at many centers for use during the Norwood procedure for single ventricle palliation. Some centers have begun to use cryopreserved femoral or saphenous venous homografts as an alternative to polytetrafluoroethylene (PTFE) for shunt construction. The immunogenicity of these homografts is unknown, and potential allosensitization could have significant implications on transplant candidacy. Methods: All patients undergoing Glenn procedure at our center between 2013 and 2020 were screened. Patients who initially underwent Norwood procedure with either PTFE or venous homograft RV-PA shunt and had available pre-Glenn serum were included in the study. The primary outcome of interest was panel reactive antibody (PRA) level at the time of Glenn surgery. Results: Thirty-six patients met inclusion criteria (N = 28 PTFE, N = 8 homograft). Patients in the homograft group had significantly higher median PRA levels at the time of Glenn surgery (0% [IQR 0-18] PTFE vs 94% [IQR 74-100] homograft, P = .003). There were no other differences between the two groups. Conclusions: Despite potential improvements in PA architecture, the use of venous homografts for RV-PA shunt construction at the time of Norwood procedure is associated with significantly elevated PRA level at the time of Glenn surgery. Centers should carefully consider the use of currently available venous homografts given the high percentage of these patients who may require future transplantation.


  • Inferior and Superior Vena Cava Saturation Monitoring After Neonatal Cardiac Surgery*

    by Mark A. Law, Alexis L. Do Benscoter, Santiago Borasino, Maya Dewan, A. K. M. Fazlur Rahman, Rohit S. Loomba, Kristal M. Msn Hock, Jeffrey A. Alten

    OBJECTIVES: Superior vena cava oxygen saturation (SVC O2) monitoring is well described for early detection of hemodynamic deterioration after neonatal cardiac surgery but inferior vena cava vein oxygen saturation (IVC O2) monitoring data are limited. DESIGN: Retrospective cohort study of 118 neonates with congenital heart disease (52 single ventricle) from February 2008 to January 2014. SETTING: Pediatric cardiac ICU. PATIENTS: Neonates (< 30 d) with concurrent admission IVC O2 and SVC O2 measurements after cardiac surgery with cardiopulmonary bypass. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary aim was to correlate admission IVC O2 and SVC O2. Secondary aims included: correlate flank or cerebral near-infrared spectroscopy with IVC O2 and SVC O2, respectively, and exploratory analysis to evaluate associations between oximetry data and a composite adverse outcome defined as any of the following: increasing serum lactate or vasoactive support at 2 hours post-admission, cardiac arrest, or mortality. Admission IVC O2 and SVC O2 correlated (r = 0.54; p < 0.001). However, IVC O2 measurements were significantly lower than paired SVC O2 (mean difference, –6%; 95% CI, –8% to –4%; p < 0.001) with wide variability in sample agreement. Logistic regression showed that each 12% decrease in IVC O2 was associated with a 12-fold greater odds of the composite adverse outcome (odds ratio [OR], 12; 95% CI, 3.9–34; p < 0.001). We failed to find an association between SVC O2 and increased odds of the composite adverse outcome (OR, 1.8; 95% CI, 0.99–3.3; p = 0.053). In an exploratory analysis, the area under the receiver operating curve for IVC O2 and SVC O2, and the composite adverse outcome, was 0.85 (95% CI, 0.77–0.92) and 0.63 (95% CI, 0.52–0.73), respectively. Admission IVC O2 had strong correlation with concurrent flank near-infrared spectroscopy value (r = 0.74; p < 0.001). SVC O2 had a weak association with cerebral near-infrared spectroscopy (r = 0.22; p = 0.02). CONCLUSIONS: In postoperative neonates, admission IVC O2 and SVC O2 correlate. Lower admission IVC O2 may identify a cohort of postsurgical neonates at risk for low cardiac output and associated morbidity.


  • Palliation Strategy to Achieve Complete Repair in Symptomatic Neonates with Tetralogy of Fallot

    by Mark A. Law, Andrew C. Glatz, Jennifer C. Romano, Paul J. Chai, Christopher E. Mascio, Christopher J. Petit, Courtney E. McCracken, Michael S. Kelleman, George T. Nicholson, Jeffery J. Meadows, et al.

    Neonates with symptomatic tetralogy of Fallot (sTOF) may undergo palliations with varying physiology, namely systemic to pulmonary artery connections (SPC) or right ventricular outflow tract interventions (RVOTI). A comparison of palliative strategies based on the physiology created is lacking. Consecutive sTOF neonates undergoing SPC or RVOTI from 2005–2017 were reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was survival with successful complete repair (CR) by 18 months. A variety of secondary outcomes were assessed including overall survival, hospitalization-related comorbidities, and interstage reinterventions. Propensity score adjustment was utilized to compare treatment strategies. The cohort included 252 SPC (surgical shunt = 226, ductus arteriosus stent = 26) and 68 RVOTI (balloon pulmonary valvuloplasty = 48, RVOT stent = 11, RVOT patch = 9) patients. Genetic syndrome (29 [42.6%] v 75 [29.8%], p = 0.04), weight < 2.5 kg (28 [41.2%] v 68 [27.0%], p = 0.023), bilateral pulmonary artery Z-score < − 2 (19 [28.0%] v 36 [14.3%], p = 0.008), and pre-intervention antegrade flow (48 [70.6%] v 104 [41.3%], p < 0.001) were more common in RVOTI. Significant center differences were noted (p < 0.001). Adjusted survival to CR by 18 months (HR = 0.87, 95% CI = 0.63–1.21, p = 0.41) and overall survival (HR = 2.08, 95% CI = 0.93–4.65, p = 0.074) were similar. RVOTI had increased interstage reintervention (HR = 2.15, 95% CI = 1.36–3.99, p = 0.001). Total anesthesia (243 [213, 277] v 328 [308, 351] minutes, p < 0.001) and cardiopulmonary bypass times (117 [103, 132] v 151 [143, 160] minutes, p < 0.001) favored RVOTI. In this multicenter comparison of physiologic palliation strategies for sTOF, survival to successful CR and overall survival were similar; however, reintervention burden was significantly higher in RVOTI.


  • Anatomical Classification and Posttreatment Remodeling Characteristics to Guide Management and Follow-Up of Neonates and Infants With Coronary Artery Fistula: A Multicenter Study From the Coronary Artery Fistula Registry

    by Srinath T. Gowda, Larry Latson, Kothandam Sivakumar, Gurumurthy Hiremath, Matthew Crystal, Mark Law, Shabana Shahanavaz, Jeremy Asnes, Surendranath Veeram Reddy, Daisuke Kobayashi, et al.

    Background: Coronary artery fistulas (CAFs) presenting in infancy are rare, and data regarding postclosure sequelae and follow-up are limited. Methods: A retrospective review of all the neonates and infants (<1 year) was conducted from the CAF registry for CAF treatment. The CAF type (proximal or distal), size, treatment method, and follow-up angiography were reviewed to assess outcomes and coronary remodeling. Results: Forty-eight patients were included from 20 centers. Of these, 30 were proximal and 18 had distal CAF; 39 were large, 7 medium, and 2 had small CAF. The median age and weight was 0.16 years (0.01–1) and 4.2 kg (1.7–10.6). Heart failure was noted in 28 of 48 (58%) patients. Transcatheter closure was performed in 24, surgical closure in 18, and 6 were observed medically. Procedural success was 92% and 94 % for transcatheter closure and surgical closure, respectively. Follow-up data were obtained in 34 of 48 (70%) at a median of 2.9 (0.1–18) years. Angiography to assess remodeling was available in 20 of 48 (41%). I. Optimal remodeling (n=10, 7 proximal and 3 distal CAF). II. Suboptimal remodeling (n=7) included (A) symptomatic coronary thrombosis (n=2, distal CAF), (B) asymptomatic coronary thrombosis (n=3, 1 proximal and 2 distal CAF), and (C) partial thrombosis with residual cul-de-sac (n=1, proximal CAF) and vessel irregularity with stenosis (n=1, distal CAF). Finally, (III) persistent coronary artery dilation (n=4). Antiplatelets and anticoagulation were used in 31 and 7 patients post-closure, respectively. Overall, 7 of 10 (70%) with proximal CAF had optimal remodeling, but 5 of 11 (45%) with distal CAF had suboptimal remodeling. Only 1 of 7 patients with suboptimal remodeling were on anticoagulation. Conclusions: Neonates/infants with hemodynamically significant CAF can be treated by transcatheter or surgical closure with excellent procedural success. Patients with distal CAF are at higher risk for suboptimal remodeling. Postclosure anticoagulation and follow-up coronary anatomic evaluation are warranted.


  • Factors Influencing Reintervention Following Ductal Artery Stent Implantation for Ductal-Dependent Pulmonary Blood Flow: Results From the Congenital Cardiac Research Collaborative

    by Shabana Shahanavaz, Athar M. Qureshi, Christopher J. Petit, Bryan H. Goldstein, Andrew C. Glatz, Holly D. Bauser-Heaton, Courtney E. McCracken, Michael S. Kelleman, Mark A. Law, George T. Nicholson, et al.

    Background: Stenting of the patent ductus arteriosus (PDA) is an established palliative option for infants with ductal-dependent pulmonary blood flow. Following initial palliation, reintervention on the PDA stent is common, but risk factors have not been characterized. Methods: Infants with ductal-dependent pulmonary blood flow palliated with PDA stent between 2008 and 2015 were reviewed within the Congenital Cardiac Research Collaborative. Rates and risk factors for reintervention were analyzed. Results: Among 105 infants who underwent successful PDA stenting, 41 patients (39%) underwent a total of 53 reinterventions on the PDA stent, with all but one occurring within 6 months of the initial intervention. Stent redilation constituted the majority of reintervention (n=35; 66%) followed by additional stent placement (n=11; 21%) and surgical shunt placement (n=7; 13%). The majority of reintervention was nonurgent, and there were no deaths during the reintervention procedure. All but one reintervention occurred within 6 months of the initial procedure. On univariate analysis, risk factors for reintervention included anticipated single-ventricle physiology, lack of prior balloon pulmonary valvuloplasty, use of drug-eluting stent, and increased ductal tortuosity. Conclusions: In infants with ductal-dependent pulmonary blood flow palliated with PDA stent implantation, reintervention is common, can be performed safely, and is associated with both anatomic/procedural factors and anticipated final physiology.